| [1] |
Mieog JS, van de Velde CJ. Neoadjuvant chemotherapy for early breast cancer[J]. Expert Opin Pharmacother, 2009,10(9): 1423-1434.
|
| [2] |
Bonadonna G. Evolving concepts in the systemic adjuvant treatment of breast cancer[J]. Cancer Res, 1992, 52(8):2127-2137.
|
| [3] |
孙强, 周易冬, 黄汉源, 等. 新辅助治疗在局部晚期乳腺癌中的应用[J]. 中国肿瘤临床, 2003, 30(4): 283-285.
|
| [4] |
Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27[J]. J Clin Oncol, 2008, 26(5): 778-785.
|
| [5] |
Fisher B, Saffer E, Rudock C, et al. Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice[J]. Cancer Res, 1989, 49(8): 2002-2004.
|
| [6] |
Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis[J].J Natl Cancer Inst, 2005, 97(3): 188-194.
|
| [7] |
Gralow JR, Burstein HJ, Wood W, et al. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease[J]. J Clin Oncol, 2008, 26(5): 814-819.
|
| [8] |
von Minckwitz G, Kummel S, Vogel P, et al. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial[J]. J Natl Cancer Inst, 2008,100(8): 542-551.
|
| [9] |
Smith IC, Heys SD, Hutcheon AW, et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel[J]. J Clin Oncol, 2002, 20(6): 1456-1466.
|
| [10] |
Esteva FJ, Hortobagyi GN. Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer[J]? J Natl Cancer Inst, 2008, 100(8): 521-523.
|
| [11] |
Kaufmann M, von Minckwitz G, Bear HD, et al. Recommen-dations from an international expert panel on the use of neoadjuvant(primary) systemic treatment of operable breast cancer: new perspectives 2006[J]. Ann Oncol, 2007, 18(12): 1927-1934.
|
| [12] |
Kaufmann M, Morrow M, von Minckwitz G, et al. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel[J]. Cancer, 2010, 116(5): 1184-1191.
|